| Issue Date | Title | Author(s) |
| 17-Sep-2014 | Ater diagnosis diabetes research support system-2 (ADDRESS-2): clinical presentation of type 1 diabetes in the beginning of the 21st century in a multi-ethnic UK cohort | Bravis, V; Kaur, A; Walkey, H; Godsland, I; Dayan, C, et al |
| 1-Jun-2017 | Clinical presentation and islet autoantibody status in a UK multi-ethnic cohort of children and adults with new-onset Type 1 diabetes-the after diabetes diagnosis research support system-2 (ADDRESS-2) | Walkey, HC; Kaur, A; Godsland, IF; Bravis, V; Misra, S, et al |
| 21-Oct-2020 | Pancreatic Sirtuin 3 deficiency promotes hepatic steatosis by enhancing 5-hydroxytryptamine synthesis in diet-induced Obese mice | Ming, X; Chung, ACK; Mao, D; Cao, H; Fan, B, et al |
| 1-Mar-2019 | Predictors of c-peptide in Type 1 diabetes within the first 60 days of diagnosis: Routine laboratory data from the After Diabetes Diagnosis Research Support System (ADDRESS-2) cohort | Kaur, A; Walkey, HC; Godsl, IF; Misra, S; Williams, AJK, et al |
| 1-Jul-2017 | Rationale and protocol for the After Diabetes Diagnosis REsearch Support System (ADDRESS): an incident and high risk type 1 diabetes UK cohort study. | Walkey, HC; Kaur, A; Bravis, V; Godsland, IF; Misra, S, et al |
| 21-Apr-2020 | Synthesis and in vivo behaviour of an exendin-4-based MRI probe capable of beta-cell-dependent contrast enhancement in the pancreas | Clough, TJ; Baxan, N; Coakley, EJ; Rivas, C; Zhao, L, et al |
| 23-Apr-2018 | Targeting GLP-1 receptor trafficking to improve agonist efficacy | Jones, B; Buenaventura, T; Kanda, N; Chabosseau, P; Owen, B, et al |